Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China
· Delayed Price · Currency is CNY 47.67
+0.29 (0.61%)
At close: Dec 5, 2025
Betta Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 414.33 | 471.68 | 752 | 731.28 | 791.99 | 1,346 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 190 | Upgrade
|
| Trading Asset Securities | 77.6 | 126.44 | 0.54 | - | 201.01 | - | Upgrade
|
| Cash & Short-Term Investments | 491.93 | 598.12 | 752.54 | 731.28 | 993 | 1,536 | Upgrade
|
| Cash Growth | -39.74% | -20.52% | 2.91% | -26.36% | -35.35% | 194.64% | Upgrade
|
| Accounts Receivable | 324.19 | 98.47 | 286.41 | 450.62 | 173.38 | 52.61 | Upgrade
|
| Other Receivables | 38.74 | 1.83 | 2.61 | 49.7 | 40.75 | 6.81 | Upgrade
|
| Receivables | 362.93 | 100.3 | 289.02 | 500.32 | 214.13 | 59.42 | Upgrade
|
| Inventory | 351.98 | 290.09 | 327.5 | 372.17 | 293.32 | 188.59 | Upgrade
|
| Prepaid Expenses | - | - | 0.2 | - | - | - | Upgrade
|
| Other Current Assets | 277.34 | 235.82 | 156.62 | 129.06 | 153.49 | 63.91 | Upgrade
|
| Total Current Assets | 1,484 | 1,224 | 1,526 | 1,733 | 1,654 | 1,848 | Upgrade
|
| Property, Plant & Equipment | 2,977 | 3,009 | 2,574 | 2,056 | 1,331 | 775.72 | Upgrade
|
| Long-Term Investments | 1,730 | 1,437 | 1,382 | 919.27 | 345.79 | 274.55 | Upgrade
|
| Goodwill | 413.58 | 413.58 | 413.58 | 413.58 | 413.58 | 413.58 | Upgrade
|
| Other Intangible Assets | 2,710 | 2,776 | 1,944 | 1,219 | 1,183 | 603.37 | Upgrade
|
| Long-Term Deferred Tax Assets | 58.57 | 56.73 | 39.13 | 85.96 | 55.06 | 55.22 | Upgrade
|
| Long-Term Deferred Charges | 209.51 | 383.53 | 1,219 | 1,444 | 1,252 | 1,171 | Upgrade
|
| Other Long-Term Assets | 115.85 | 41.99 | 50.3 | 39.3 | 37.6 | 87.79 | Upgrade
|
| Total Assets | 9,699 | 9,342 | 9,147 | 7,910 | 6,271 | 5,230 | Upgrade
|
| Accounts Payable | 750.68 | 746.11 | 800.12 | 35.85 | 431.19 | 113.62 | Upgrade
|
| Accrued Expenses | 133.59 | 285.53 | 357.82 | 419.11 | 357.02 | 187.53 | Upgrade
|
| Short-Term Debt | 105.09 | 100.08 | 300.27 | 380.39 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 730.64 | 639.85 | 301.25 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 33.03 | 4.6 | 4.16 | 4.88 | - | Upgrade
|
| Current Income Taxes Payable | 72.69 | 4.26 | 0.07 | 0.04 | 10.68 | 27.54 | Upgrade
|
| Current Unearned Revenue | 2.17 | 2.63 | 4.92 | 4.46 | 0.69 | 1.27 | Upgrade
|
| Other Current Liabilities | 132.31 | 36.47 | 34.11 | 1,261 | 84.4 | 108.14 | Upgrade
|
| Total Current Liabilities | 1,927 | 1,848 | 1,803 | 2,105 | 888.86 | 438.1 | Upgrade
|
| Long-Term Debt | 1,549 | 1,552 | 1,816 | 656.03 | - | 2.6 | Upgrade
|
| Long-Term Leases | 75.65 | 71.63 | 8.18 | 7.3 | 6.34 | - | Upgrade
|
| Long-Term Unearned Revenue | 192.7 | 150.99 | 144.7 | 112.76 | 112 | 58.01 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 35.76 | 53.49 | 23.39 | 71.57 | 68.39 | 64.64 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 510.06 | 521.99 | Upgrade
|
| Total Liabilities | 3,780 | 3,676 | 3,795 | 2,952 | 1,586 | 1,085 | Upgrade
|
| Common Stock | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 | 413.16 | Upgrade
|
| Additional Paid-In Capital | 2,067 | 1,945 | 1,945 | 1,860 | 1,932 | 1,793 | Upgrade
|
| Retained Earnings | 3,067 | 2,834 | 2,503 | 2,181 | 2,139 | 1,883 | Upgrade
|
| Comprehensive Income & Other | 288.64 | 375.78 | 384.48 | 390.99 | 74.64 | 52.28 | Upgrade
|
| Total Common Equity | 5,843 | 5,574 | 5,251 | 4,849 | 4,561 | 4,141 | Upgrade
|
| Minority Interest | 76.16 | 92.3 | 100.4 | 108.64 | 124.9 | 3.41 | Upgrade
|
| Shareholders' Equity | 5,920 | 5,666 | 5,351 | 4,958 | 4,686 | 4,144 | Upgrade
|
| Total Liabilities & Equity | 9,699 | 9,342 | 9,147 | 7,910 | 6,271 | 5,230 | Upgrade
|
| Total Debt | 2,460 | 2,396 | 2,430 | 1,048 | 11.22 | 2.6 | Upgrade
|
| Net Cash (Debt) | -1,968 | -1,798 | -1,678 | -316.59 | 981.77 | 1,533 | Upgrade
|
| Net Cash Growth | - | - | - | - | -35.97% | - | Upgrade
|
| Net Cash Per Share | -4.68 | -4.29 | -4.00 | -0.76 | 2.36 | 3.77 | Upgrade
|
| Filing Date Shares Outstanding | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 | 413.16 | Upgrade
|
| Total Common Shares Outstanding | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 | 413.16 | Upgrade
|
| Working Capital | -442.98 | -623.63 | -277.28 | -371.95 | 765.08 | 1,410 | Upgrade
|
| Book Value Per Share | 13.89 | 13.32 | 12.55 | 11.62 | 10.98 | 10.02 | Upgrade
|
| Tangible Book Value | 2,720 | 2,384 | 2,894 | 3,216 | 2,964 | 3,124 | Upgrade
|
| Tangible Book Value Per Share | 6.46 | 5.70 | 6.92 | 7.70 | 7.14 | 7.56 | Upgrade
|
| Buildings | - | 2,952 | 586.14 | 585.59 | 627.19 | 588.32 | Upgrade
|
| Machinery | - | 449.64 | 424.26 | 402.25 | 376.01 | 339.24 | Upgrade
|
| Construction In Progress | - | 191.87 | 2,037 | 1,448 | 639.67 | 63.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.